| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.05. | Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer? | 113 | Business Wire | BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety... ► Artikel lesen | |
| 23.05. | Bowhead Specialty Announces Pricing of Upsized Initial Public Offering | 123 | Business Wire | NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the "Company", "Bowhead Specialty", "we" or "our") announced today the pricing of its upsized initial public offering of 7,529,412 shares... ► Artikel lesen | |
| 23.05. | Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results | 794 | Business Wire | BASKING RIDGE, N.J.--(BUSINESS WIRE)--Barnes & Noble Education, Inc. (NYSE: BNED) ("BNED" or the "Company"), a leading solutions provider for the education industry, today announced certain preliminary... ► Artikel lesen | |
| 23.05. | SatixFy Announces First Quarter 2024 Results | 152 | Business Wire | REHOVOT, Israel--(BUSINESS WIRE)--SatixFy Communications Ltd. (the "Company" or "SatixFy") (NYSE American: SATX), a pioneering force in next-generation satellite communication systems driven by... ► Artikel lesen | |
| 23.05. | Domo, Inc. Announces First Quarter Fiscal 2025 Financial Results | 158 | Business Wire | SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo, Inc. (Nasdaq: DOMO) today announced results for its fiscal first quarter ended April 30, 2024.
Fiscal First Quarter Results
Total revenue was... ► Artikel lesen | |
| 23.05. | American Woodmark Announces Fiscal Fourth Quarter and Fiscal Year Results | 650 | Business Wire | WINCHESTER, Va.--(BUSINESS WIRE)--American Woodmark Corporation (NASDAQ: AMWD) (the "Company") today announced results for its fourth fiscal quarter ended April 30, 2024 and its fiscal year ended... ► Artikel lesen | |
| 23.05. | Ross Stores Reports First Quarter Earnings | 506 | Business Wire | DUBLIN, Calif.--(BUSINESS WIRE)--Ross Stores, Inc. (NASDAQ: ROST) today reported earnings per share for the 13 weeks ended May 4, 2024 of $1.46 on net earnings of $488 million. These results compare... ► Artikel lesen | |
| 23.05. | Intuit Reports Strong Third Quarter Results and Raises Full Year Guidance | 847 | Business Wire | MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Intuit Inc. (NASDAQ: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, announced financial... ► Artikel lesen | |
| 23.05. | Selina Hospitality PLC Receives Nasdaq Notice and Provides Update on Nasdaq Hearings Panel | 317 | Business Wire | NEW YORK--(BUSINESS WIRE)--Selina Hospitality PLC ("Selina" or the "Company"; NASDAQ: SLNA), a global lifestyle and experiential hospitality company catering to millennial and Gen Z travelers, announces... ► Artikel lesen | |
| 23.05. | Exicure, Inc. Received Nasdaq Notice of a Delisting Determination | 175 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today it received notice of a delisting determination (the "Staff Delisting Determination") from the... ► Artikel lesen | |
| 23.05. | Genmab A/S: Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting | 710 | Business Wire | Six oral and poster presentations will highlight breadth of clinical program and potential utility of epcoritamab-bysp in patients with difficult-to-treat lymphomas across multiple lines of therapy... ► Artikel lesen | |
| 23.05. | Bicycle Therapeutics plc: Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting | 373 | Business Wire | Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational... ► Artikel lesen | |
| 23.05. | Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024 | 810 | Business Wire | First-in-human data for potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in treatment of metastatic colorectal cancer to be featured in oral presentation... ► Artikel lesen | |
| 23.05. | NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | 392 | Business Wire | Assay identified 98% of relapses and 100% of cutaneous melanoma-related deaths in stage IB/IIA patients
Patients with stage IB/IIA melanoma identified as high-risk had a relapse rate comparable... ► Artikel lesen | |
| 23.05. | SOTIO Biotech: SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting | 449 | Business Wire | Patient enrollment and dosing ongoing in first-in-human study of BOXR1030 enhanced CAR T-cell therapy SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, will present... ► Artikel lesen | |
| 23.05. | Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms | 759 | Business Wire | Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting... ► Artikel lesen | |
| 23.05. | Corsearch: Weltweite Zahl aktiver Marken passiert 100-Millionen-Marke in zwei Jahren | 215 | Business Wire | Einer Prognose von Corsearch zufolge werden 2026 weltweit mehr als 100 Millionen aktive Marken angemeldet sein was eine Verdoppelung im Verlauf eines Jahrzehnts bedeutet Mit dem Relaunch... ► Artikel lesen | |
| 23.05. | Affinity ernennt Ken Fine zum CEO | 270 | Business Wire | Affinity, die Beziehungsintelligenz-Plattform für Geschäftsleute, hat heute bekannt gegeben, dass Ken Fine neuer CEO des Unternehmens wird. Mit mehr als 20 Jahren Erfahrung in der Führung von B2B... ► Artikel lesen | |
| 23.05. | On Elects Laura Miele as a New Independent Member of the Board of Directors | 391 | Business Wire | Swiss performance sportswear brand On (NYSE: ONON) announced today the election of Laura Miele as an additional independent member of the Board of Directors. Ms. Miele will also serve as a member... ► Artikel lesen | |
| 23.05. | Stevanato Group S.p.A.: Stevanato Group to Present at Upcoming Investor Conferences | 313 | Business Wire | Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 654 |
| NVIDIA | 431 |
| BAYER | 366 |
| SUPER MICRO COMPUTER | 272 |
| RHEINMETALL | 240 |
| MICROSTRATEGY | 232 |
| TESLA | 229 |
| NEL | 171 |
| PALANTIR TECHNOLOGIES | 163 |
| BIONTECH | 154 |
| VOLKSWAGEN | 152 |
| TUI | 144 |
| BYD | 131 |
| DEUTSCHE TELEKOM | 122 |
| BASF | 118 |
| MERCEDES-BENZ | 104 |
| DEUTSCHE BANK | 102 |
| THYSSENKRUPP | 100 |
| AMAZON | 97 |
| ALLIANZ | 95 |
| BITCOIN GROUP SE | 95 |
| RENK GROUP | 95 |
| PFIZER | 93 |
| COMMERZBANK | 92 |
| RWE | 88 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
